{"id":"https://openalex.org/W7201865237","doi":"https://doi.org/10.1016/j.celrep.2026.118216","title":"eHLAstic reveals an extended canonical and non-canonical HLA-E immunopeptidome in human cancers","display_name":"eHLAstic reveals an extended canonical and non-canonical HLA-E immunopeptidome in human cancers","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7201865237","doi":"https://doi.org/10.1016/j.celrep.2026.118216","pmid":"https://pubmed.ncbi.nlm.nih.gov/42981192"},"language":"en","primary_location":{"id":"doi:10.1016/j.celrep.2026.118216","doi":"https://doi.org/10.1016/j.celrep.2026.118216","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.celrep.2026.118216","pdf_url":null,"source":{"id":"https://openalex.org/S169236886","display_name":"Cell Reports","issn_l":"2211-1247","issn":["2211-1247","2639-1856"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-200","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.celrep.2026.118216","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066455104","display_name":"Hanqing Liao","orcid":"https://orcid.org/0000-0002-0953-4354","observed_orcids":["https://orcid.org/0000-0002-0953-4354"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hanqing Liao","raw_affiliation_strings":["School of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, UK"],"raw_orcid":"https://orcid.org/0000-0002-0953-4354","affiliations":[{"raw_affiliation_string":"School of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, UK","institution_ids":["https://openalex.org/I177639307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013833418","display_name":"Max N. Quastel","orcid":"https://orcid.org/0000-0001-6551-4713","observed_orcids":["https://orcid.org/0000-0001-6551-4713"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Max N. Quastel","raw_affiliation_strings":["Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK"],"raw_orcid":"https://orcid.org/0000-0001-6551-4713","affiliations":[{"raw_affiliation_string":"Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111184741","display_name":"Chloe M. Shepherd","orcid":"https://orcid.org/0000-0002-0149-7448","observed_orcids":["https://orcid.org/0000-0002-0149-7448"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Chloe M. Shepherd","raw_affiliation_strings":["School of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, UK"],"raw_orcid":"https://orcid.org/0000-0002-0149-7448","affiliations":[{"raw_affiliation_string":"School of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, UK","institution_ids":["https://openalex.org/I177639307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059362144","display_name":"Annalisa Nicastri","orcid":"https://orcid.org/0000-0002-1895-0317","observed_orcids":["https://orcid.org/0000-0002-1895-0317"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Annalisa Nicastri","raw_affiliation_strings":["Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK; The Institute for Cancer Research, London SW3 6JB, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK; The Institute for Cancer Research, London SW3 6JB, UK","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091972070","display_name":"Leron W. Kok","orcid":"https://orcid.org/0009-0008-0841-2313","observed_orcids":["https://orcid.org/0009-0008-0841-2313"]},"institutions":[{"id":"https://openalex.org/I4210111138","display_name":"Oncode Institute","ror":"https://ror.org/01n92vv28","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210111138"]},{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Leron W. Kok","raw_affiliation_strings":["Princess M\u00e1xima Center for Pediatric Oncology, 3584 CS Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands"],"raw_orcid":"https://orcid.org/0009-0008-0841-2313","affiliations":[{"raw_affiliation_string":"Princess M\u00e1xima Center for Pediatric Oncology, 3584 CS Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210111138","https://openalex.org/I4210127118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038466528","display_name":"Andy van Hateren","orcid":"https://orcid.org/0000-0002-3915-0239","observed_orcids":["https://orcid.org/0000-0002-3915-0239"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andy van Hateren","raw_affiliation_strings":["Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK"],"raw_orcid":"https://orcid.org/0000-0002-3915-0239","affiliations":[{"raw_affiliation_string":"Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072042710","display_name":"Sam Palmer","orcid":"https://orcid.org/0000-0002-5036-6073","observed_orcids":["https://orcid.org/0000-0002-5036-6073"]},"institutions":[{"id":"https://openalex.org/I125608817","display_name":"Korea Institute for Advanced Study","ror":"https://ror.org/041hz9568","country_code":"KR","type":"facility","lineage":["https://openalex.org/I125608817"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Sam Palmer","raw_affiliation_strings":["Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK; School of Computational Sciences, Korea Institute for Advanced Study, Seoul 02455, Korea"],"raw_orcid":"https://orcid.org/0000-0002-5036-6073","affiliations":[{"raw_affiliation_string":"Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK; School of Computational Sciences, Korea Institute for Advanced Study, Seoul 02455, Korea","institution_ids":["https://openalex.org/I125608817"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101668457","display_name":"Qian Yang","orcid":"https://orcid.org/0000-0001-8157-1654","observed_orcids":["https://orcid.org/0000-0001-8157-1654"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Yang","raw_affiliation_strings":["Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK"],"raw_orcid":"https://orcid.org/0000-0001-8157-1654","affiliations":[{"raw_affiliation_string":"Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160611369","display_name":"Aleksandra Dzhoneva","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleksandra Dzhoneva","raw_affiliation_strings":["Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078290882","display_name":"Bas W. A. Peeters","orcid":"https://orcid.org/0000-0003-4463-7460","observed_orcids":["https://orcid.org/0000-0003-4463-7460"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bas Peeters","raw_affiliation_strings":["Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK"],"raw_orcid":"https://orcid.org/0000-0003-4463-7460","affiliations":[{"raw_affiliation_string":"Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025483617","display_name":"Estelle Marrer\u2010Berger","orcid":"https://orcid.org/0000-0002-9677-0549","observed_orcids":["https://orcid.org/0000-0002-9677-0549"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Estelle Marrer-Berger","raw_affiliation_strings":["Drug Development Consultancy, 4059 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Drug Development Consultancy, 4059 Basel, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160622130","display_name":"Sebastiaan van Heesch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210111138","display_name":"Oncode Institute","ror":"https://ror.org/01n92vv28","country_code":"NL","type":"education","lineage":["https://openalex.org/I4210111138"]},{"id":"https://openalex.org/I4210127118","display_name":"Princess M\u00e1xima Center","ror":"https://ror.org/02aj7yc53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210127118"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Sebastiaan van Heesch","raw_affiliation_strings":["Princess M\u00e1xima Center for Pediatric Oncology, 3584 CS Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess M\u00e1xima Center for Pediatric Oncology, 3584 CS Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I4210111138","https://openalex.org/I4210127118"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015393082","display_name":"Geraldine M. A. Gillespie","orcid":"https://orcid.org/0000-0002-1075-870X","observed_orcids":["https://orcid.org/0000-0002-1075-870X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geraldine M. Gillespie","raw_affiliation_strings":["Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090536136","display_name":"Nicola Ternette","orcid":"https://orcid.org/0000-0002-9283-0743","observed_orcids":["https://orcid.org/0000-0002-9283-0743"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Nicola Ternette","raw_affiliation_strings":["School of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, UK; Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK. Electronic address: nternette001@dundee.ac.uk"],"raw_orcid":"https://orcid.org/0000-0002-9283-0743","affiliations":[{"raw_affiliation_string":"School of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, UK; Centre for Immuno-Oncology, Nuffield Department of Medicine, England OX3 7DQ, UK. Electronic address: nternette001@dundee.ac.uk","institution_ids":["https://openalex.org/I177639307"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5090536136"],"corresponding_institution_ids":["https://openalex.org/I177639307"],"apc_list":{"value":5620,"currency":"USD","value_usd":5620},"apc_paid":{"value":5620,"currency":"USD","value_usd":5620},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"45","issue":"11","first_page":"118216","last_page":"118216"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.007799999788403511,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hla-e","display_name":"HLA-E","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immunopeptidome","display_name":"immunopeptidome","score":0.8460000157356262},{"id":"https://openalex.org/keywords/non-classical-mhc-class-i","display_name":"non-classical MHC class I","score":0.8429999947547913},{"id":"https://openalex.org/keywords/leukemia","display_name":"leukemia","score":0.6140000224113464},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.746999979019165},{"id":"https://openalex.org/keywords/myeloid-leukemia","display_name":"myeloid leukemia","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.6046000123023987},{"id":"https://openalex.org/C2992972558","wikidata":"https://www.wikidata.org/wiki/Q2509220","display_name":"Blood cancer","level":3,"score":0.569599986076355},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5188000202178955},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.4927999973297119},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4918000102043152},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4661000072956085},{"id":"https://openalex.org/C3018844941","wikidata":"https://www.wikidata.org/wiki/Q6718887","display_name":"Non canonical","level":2,"score":0.448199987411499},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44350001215934753},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.42089998722076416},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.41929998993873596},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.39649999141693115},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.39250001311302185},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.3894999921321869},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38679999113082886},{"id":"https://openalex.org/C170627219","wikidata":"https://www.wikidata.org/wiki/Q13218497","display_name":"MHC class I","level":4,"score":0.3528999984264374},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3319000005722046},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3278000056743622},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3278000056743622},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.31700000166893005},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.28290000557899475},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2815000116825104},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.2745000123977661},{"id":"https://openalex.org/C2994430510","wikidata":"https://www.wikidata.org/wiki/Q3270846","display_name":"Myeloid cells","level":3,"score":0.26429998874664307},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.26339998841285706},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.25949999690055847},{"id":"https://openalex.org/C1547928","wikidata":"https://www.wikidata.org/wiki/Q1660177","display_name":"Immunogenetics","level":3,"score":0.25589999556541443},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.25440001487731934},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.25290000438690186}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1016/j.celrep.2026.118216","doi":"https://doi.org/10.1016/j.celrep.2026.118216","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.celrep.2026.118216","pdf_url":null,"source":{"id":"https://openalex.org/S169236886","display_name":"Cell Reports","issn_l":"2211-1247","issn":["2211-1247","2639-1856"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-200","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Reports","raw_type":"journal-article"},{"id":"doi:10.2139/ssrn.7247352","doi":"https://doi.org/10.2139/ssrn.7247352","is_oa":true,"landing_page_url":"https://doi.org/10.2139/ssrn.7247352","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmid:42981192","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42981192","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell reports","raw_type":"Journal Article"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire/ad472049-7279-4290-8e02-fd8087b89ab2","doi":null,"is_oa":true,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/ad472049-7279-4290-8e02-fd8087b89ab2","pdf_url":"https://discovery.dundee.ac.uk/ws/files/181333579/1-s2.0-S2211124726012957-main.pdf","source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Liao, H, Quastel, M N, Nicastri, A, Kok, L W, van Hateren, A, Palmer, S, Yang, Q, Dzhoneva, A, Peeters, B, Marrer-Berger, E, van\u00a0Heesch, S, Gillespie, G M & Ternette, N 2026, 'eHLAstic reveals an extended canonical and non-canonical HLA-E immunopeptidome in human cancers', Cell Reports, vol. 45, no. 11, 118216. https://doi.org/10.1016/j.celrep.2026.118216","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:1d4d32e936eb4ad49856393c3cf5ea97","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/1d4d32e936eb4ad49856393c3cf5ea97","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cell Reports, Vol 45, Iss 11, Pp 118216- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.celrep.2026.118216","doi":"https://doi.org/10.1016/j.celrep.2026.118216","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.celrep.2026.118216","pdf_url":null,"source":{"id":"https://openalex.org/S169236886","display_name":"Cell Reports","issn_l":"2211-1247","issn":["2211-1247","2639-1856"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-200","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cell Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306137","display_name":"Bill and Melinda Gates Foundation","ror":"https://ror.org/0456r8d26"},{"id":"https://openalex.org/F4320310838","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36"},{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320331496","display_name":"Oncode Institute","ror":"https://ror.org/01n92vv28"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7201865237.pdf","grobid_xml":"https://content.openalex.org/works/W7201865237.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1164513168","https://openalex.org/W1506397040","https://openalex.org/W1534477342","https://openalex.org/W1979273031","https://openalex.org/W1981844137","https://openalex.org/W1989166597","https://openalex.org/W1993273815","https://openalex.org/W2030307609","https://openalex.org/W2039266996","https://openalex.org/W2042492069","https://openalex.org/W2045585289","https://openalex.org/W2056750119","https://openalex.org/W2105878567","https://openalex.org/W2116171543","https://openalex.org/W2136558573","https://openalex.org/W2143210482","https://openalex.org/W2144099498","https://openalex.org/W2144891041","https://openalex.org/W2802183755","https://openalex.org/W2887575266","https://openalex.org/W2902856530","https://openalex.org/W2945679805","https://openalex.org/W2974901045","https://openalex.org/W3024570138","https://openalex.org/W3045516333","https://openalex.org/W3103755024","https://openalex.org/W3134746059","https://openalex.org/W3139273669","https://openalex.org/W3156888771","https://openalex.org/W3205324211","https://openalex.org/W4205192056","https://openalex.org/W4256407664","https://openalex.org/W4282942114","https://openalex.org/W4295477357","https://openalex.org/W4385700734","https://openalex.org/W4387700900","https://openalex.org/W4390535824","https://openalex.org/W4391103249","https://openalex.org/W4393013645","https://openalex.org/W4404511368","https://openalex.org/W4406045417","https://openalex.org/W4410216284","https://openalex.org/W4413033903","https://openalex.org/W7124451008","https://openalex.org/W7160397057"],"related_works":["https://openalex.org/W7164180365","https://openalex.org/W1998307950","https://openalex.org/W157022731","https://openalex.org/W4295762028","https://openalex.org/W3156888771","https://openalex.org/W3010737707","https://openalex.org/W3120336250","https://openalex.org/W7134037235","https://openalex.org/W2975110369","https://openalex.org/W2971621113"],"abstract_inverted_index":{"HLA-E":[0,23,50,133,140],"is":[1,30],"a":[2,12,41],"non-classical":[3],"MHC":[4],"class":[5],"I":[6],"molecule":[7],"with":[8,56,101,142],"restricted":[9,33],"polymorphism,":[10],"offering":[11],"putative":[13],"path":[14],"to":[15,34],"broadly":[16],"applicable":[17],"off-the-shelf":[18],"therapies.":[19],"Yet,":[20],"the":[21,47,132],"wider":[22],"peptide":[24],"repertoire":[25],"remains":[26],"poorly":[27],"defined":[28],"and":[29,61,71,83,105,110,124,135,138,147],"largely":[31],"assumed":[32],"signal":[35],"peptide-derived":[36],"sequences.":[37],"We":[38],"developed":[39],"eHLAstic,":[40],"dedicated":[42],"HLA-E-binding":[43],"predictor,":[44],"that":[45],"improved":[46],"precision":[48],"of":[49],"ligand":[51],"discovery":[52],"almost":[53],"3-fold":[54],"compared":[55],"existing":[57],"approaches.":[58],"Using":[59],"eHLAstic":[60],"orthogonal":[62],"biochemical":[63],"validation,":[64],"we":[65],"report":[66],"30":[67],"previously":[68],"unrecognized":[69],"canonical":[70,137],"non-canonical":[72,116,139],"HLA-E-associated":[73],"peptides,":[74],"including":[75],"six":[76],"cancer-restricted":[77],"ligands":[78,96,117,141],"detected":[79,107,119],"in":[80,121,126],"acute":[81],"lymphoblastic":[82],"myeloid":[84],"leukemia":[85],"but":[86,114],"not":[87,125],"healthy":[88,127],"blood":[89],"or":[90],"bone":[91],"marrow":[92],"cells.":[93],"Most":[94],"identified":[95],"were":[97,106,118],"shared":[98],"across":[99,108],"individuals":[100],"diverse":[102],"HLA":[103],"backgrounds":[104],"hematological":[109],"solid":[111],"cancers.":[112],"All":[113],"one":[115],"exclusively":[120],"cancer-associated":[122],"samples":[123],"tissues.":[128],"These":[129],"findings":[130],"redefine":[131],"ligandome":[134],"uncover":[136],"potential":[143],"for":[144],"immune":[145],"recognition":[146],"therapeutic":[148],"targeting.":[149]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-08-08T00:00:00"}
